For the Inventor, By the Inventor

Enter inventor name

Reading, MA, United States of America

Kevin James Filipski

USPTO Granted Patents = 18 (Patent Applications = 11)

CIPO Patents = 8 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 58(Granted Patents)

Location History:

Canton, MI (US) (2006 - 2008)
Ivoryton, CT (US) (2013 - 2014)
Reading, MA (US) (2014 - 2023)

Company Filing History:

17 out of 4,455

Pfizer Corporation

1 out of 832,680

Other

patents

Years Active: 2006-2025

Loading Chart...

Loading Chart...

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12466803 - BCKDK inhibitors and/or degraders (2025-11-11),

2. 11542270 - BCKDK inhibitors (2023-01-03),

3. 11471458 - Diacylglycerol acyl transferase 2 inhibitor (2022-10-18),

4. 11065249 - Diacylglycerol acyl transferase 2 inhibitor (2021-07-20),

5. 11059833 - BCKDK inhibitors (2021-07-13),

6. 9452999 - Glucagon receptor modulators (2016-09-27),

7. 9394285 - Indole and indazole compounds that activate AMPK (2016-07-19),

8. 9139538 - Quinolinyl glucagon receptor modulators (2015-09-22),

9. 9073871 - Glucagon receptor modulators (2015-07-07),

10. 9056834 - Glucagon receptor modulators (2015-06-16),

11. 8933104 - Glucagon receptor modulators (2015-01-13),

12. 8927577 - Quinolinyl glucagon receptor modulators (2015-01-06),

13. 8889730 - Indole and indazole compounds that activate AMPK (2014-11-18),

14. 8859591 - Glucagon receptor modulators (2014-10-14),

15. 8809342 - Glucagon receptor modulators (2014-08-19),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…